Skip to main content

Table 1 Baseline characteristics

From: Clinical outcomes of bicuspid versus tricuspid aortic valve stenosis after transcatheter aortic valve replacement with self-expandable valves

 

TYPE0

BAV (n = 86)

TYPE1

BAV (n = 109)

TAV

(n = 149)

P value

Age(yrs)

72.90 ± 7.06

76.31 ± 7.17

77.05 ± 9.32

0.001

Sex, male(n.%)

41 (47.67)

55 (50.46)

77 (51.68)

0.839

BMI

23.86 ± 2.84

23.05 ± 2.93

23.96 ± 3.75

0.085

NYHA ≥ III(n.%)

68 (79.07)

91 (83.49)

122 (81.88)

0.729

STS score

4.15 ± 1.79

4.50 ± 1.59

5.14 ± 2.15

< 0.001

Hypertension(n.%)

32 (37.21)

57 (52.29)

111 (74.50)

< 0.001

Diabetes mellitus (n.%)

18 (20.93)

18 (16.51)

43 (28.86)

0.058

Creatine(mg/dL)

92.52 ± 91.05

96.22 ± 49.26

119.17 ± 121.68

0.068

Peripheral vascular disease(n.%)

6 (6.98)

16 (14.68)

25 (16.78)

0.101

Prior cerebrovascular(n.%) accident

6 (6.98)

8 (7.34)

11 (7.38)

0.914

Chronic lung disease(n.%)

45 (52.33)

62 (56.88)

79 (53.02)

0.772

Cardiac history(n.%)

    

  PCI

6 (6.98)

8 (7.34)

20 (13.42)

0.157

  CABG

1 (1.16)

1 (0.92)

5 (3.36)

0.383

  AF/Af

21 (24.42)

22 (20.18)

27 (18.12)

0.526

  Pre-existing pacemaker

2 (2.33)

4 (3.67)

3 (2.01)

0.696

Echocardiographic findings

    

  Mean gradient(mmHg)

49.06 ± 20.81

45.37 ± 17.15

44.39 ± 15.42

0.152

  Aortic valve area(mm²)

0.62 ± 0.12

0.74 ± 0.43

0.69 ± 0.15

0.073

  LVEF(%)

56.26 ± 15.51

55.83 ± 12.98

55.44 ± 15.71

0.920

  Maximum aortic valve Velocity(m/s)

4.90 ± 0.81

4.77 ± 0.72

4.65 ± 0.76

0.528

  Moderate-to-severe aortic regurgitation (n.%)

4 (4.65)

4 (3.67)

14 (9.40)

0.161

  Moderate-to-se vere mitral regurgitation

2 (2.33)

2 (1.83)

9( 6.04)

0.207

Pre-CT data

    

  Annulus

    

  Area(mm²)

467 (419–548)

496(431–567)

441(377–490)

0.475

  Perimeter(mm)

80.30 ± 7.01

81.98 ± 8.35

80.61 ± 7.67

0.336

  RCA height(mm)

15.88 ± 3.61

14.97 ± 3.73

14.84 ± 3.07

0.584

  LM height(mm)

17.35 ± 3.59

15.44 ± 3.20

15.92 ± 3.46

0.115

  Total leaflet CV(mm³)

511 (287.73-885.53)

622.50 (359.70-915.80)

417 (217–714.00)

< 0.001

  Total LVOT CV(mm³)

0 (0-34.28)

0 (0-33.05)

0 (0-28.93)

0.547

  Excess leaflet calcification(n,%)

45 (52.33)

68 (62.39)

57 (38.26)

 

  Moderate to severe LVOT calcification(n,%)

27 (31.40)

30 (27.52)

41 (27.52)

0.878

  1. BAV bicuspid aortic valve, BMI body mass index, NYHA New York Heart Association, STS Society of Thoracic Surgeons, PCI percutaneous coronary artery intervention, AF atrial fibrillation, Af atrial flutter, CABG Coronary artery bypass grafting, LVEF left ventricular ejection fraction, CT computed tomography, RCA right coronary artery, LM left main, LVOT left ventricular outflow tract, CV calcium volume